Barbara Yanni serves as a Strategic Advisor at One Zyme since July 2025, leveraging pharmaceutical and biotech expertise to enhance the company's initiatives in AI for business development and competitive intelligence. Yanni holds multiple board positions, including memberships at Delsona Therapeutics, Pharming Group, and Mesentech, among others. Notable past roles include chairing Akcea Therapeutics' Affiliate Transactions Committee, where negotiation efforts led to the successful acquisition by Ionis. Yanni's educational background includes studies at Stanford Law School and Wellesley College.
This person is not in the org chart
This person is not in any teams
This person is not in any offices